Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Myelodysplastic Syndromes 19 Lymphoma, Non-Hodgkin 17 Leukemia, Lymphocytic, Chronic, B-Cell 15 Hodgkin Disease 15 Graft vs Host Disease 13 Lymphoma, Mantle-Cell 12 Leukemia 12 Multiple Myeloma 11 Lymphoma, Large B-Cell, Diffuse 11 Sarcoma 10 Lymphoma 10 Lymphoma, Follicular 9 Lymphoma, B-Cell, Marginal Zone 9 Burkitt Lymphoma 9 Myeloproliferative Disorders 8 Waldenstrom Macroglobulinemia 7 Tuberous Sclerosis 7 Neoplasms 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Hematologic Neoplasms 7 Congenital Abnormalities 7 Primary Myelofibrosis 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Myeloid, Chronic-Phase 6 Leukemia, Myeloid, Accelerated Phase 6 Breast Neoplasms 6 Osteosarcoma 5

Interventions

pembrolizumab 31 Gemcitabine 26 Nivolumab 20 atezolizumab 16 Cisplatin 15 avelumab 14 Carboplatin 12 Docetaxel 10 enfortumab vedotin 8 Magnetic Resonance Spectroscopy 8 durvalumab 7 Specimen Handling 7 Paclitaxel 7 Ipilimumab 6 toripalimab 5 pemigatinib 5 cabozantinib 5 vinflunine 4 sacituzumab govitecan 4 Taxes 4 Pemetrexed 4 tislelizumab 3 cabazitaxel 3 Standard of Care 3 Mitomycin 3 Injections 3 Everolimus 3 Albumin-Bound Paclitaxel 3 sapanisertib 2 olaparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Transitional Cell × Sirolimus × Clear all

NCT01856101 2019-04-10

BEZ235

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Terminated

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡